Advances in R/R Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Gain expert pharmacist perspective on newly approved and emerging therapies for relapsed/refractory multiple myeloma with a webcast of a live webinar plus downloadable slidesets.

Share

Program Content

Activities

Advances in R/R Multiple Myeloma: Webcast
Advances in R/R Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: May 28, 2021

Expires: May 27, 2022

Activities

Advances in R/R MM
Advances in Relapsed/Refractory Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 04, 2021

Expires: May 03, 2022

<i>EP</i>: R/R MM
ExpressPoints
Advances in Relapsed/Refractory Myeloma: Practical Guidance for Newly Approved and Emerging Therapies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 14, 2021

Expires: May 13, 2022

Faculty

cover img faculity

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

cover img faculity

Kathryn Maples, PharmD, BCOP

Clinical Pharmacy Specialist, Multiple Myeloma
Department of Pharmacy
Emory Healthcare
Winship Cancer Institute
Atlanta, Georgia

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Bristol Myers Squibb

Karyopharm Therapeutics